This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Celgene Quanticel Research, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jessica Jang
Introduction
Jessica Jang is a prominent inventor based in New York, NY (US). She has made significant strides in the field of medical research, particularly in the treatment of leukemia and myelodysplastic syndrome. Her work has the potential to impact many lives through innovative therapeutic methods.
Latest Patents
Jessica Jang holds a patent for her invention titled "Azacitidine in combination with venetoclax, gilteritinib, midostaurin or other compounds for treating leukemia or myelodysplastic syndrome." This patent outlines methods for using 5-azacytidine in combination with additional agents to treat diseases and disorders, including acute myeloid leukemia (AML). This innovative approach showcases her commitment to advancing cancer treatment.
Career Highlights
Jessica is currently associated with Celgene Quanticel Research, Inc., where she continues to develop groundbreaking therapies. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Jessica has collaborated with notable colleagues, including Diana R Dunshee and Shelonitda Rose. These partnerships enhance her research efforts and contribute to the development of effective treatments.
Conclusion
Jessica Jang's contributions to medical research and her innovative patent demonstrate her commitment to improving patient outcomes in the field of oncology. Her work is a testament to the impact that dedicated inventors can have on healthcare advancements.